Delivery Order SPE2DB22D3501-SPE2DB25FTJ57

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLIA 60 MG/ML SYRINGE. The contract has a ceiling value of $10,992.94 and is a firm fixed-price delivery order that runs through November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award SPE2DB22D1202|SPE2DB25FULY2, valued at $25,173.10, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Prolia 60 mg/ml syringes, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 10, 2024. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,191.71, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a medication. The contract is a firm fixed price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.90 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML SYRINGE medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award is for the delivery of PROLIA 60 MG/ML syringes, awarded to the prime contractor AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a total ceiling value of $42,850.78 and runs through December 16, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROLIA 60 MG/ML syringes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,142.90 and an ultimate completion date of March 27, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,733.97, is a Firm Fixed Price Delivery Order for the supply of PROLIA 60 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of November 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with an ID of SPE2DB25D3017|SPE2DB25FVHGN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,328.50, is a Firm Fixed Price Delivery Order for the supply of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, SPE2DB20D3103|SPE2DB25FN2J1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $37,809.00 and a period of performance through March 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, with an ID of SPE2DB24D1104|SPE2DB25FXVN2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLIA 60 MG/ML SYRINGE ML, with a total ceiling value of $2,802.57 and a completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTJ57
    Delivery Order

This federal contract award SPE2DB22D3501|SPE2DB25FTJ57, valued at $15,032.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 4, 2024. The award was made on November 1, 2024, and there was no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:55 PM